Our Solution

Enabling  Scaling Manufacturing of Cell and Gene Therapies by empowering Therapy developers to fully utilise manufacturing capabilities, through innovative software solutions


AutoloMATE's 3 Phased Approach

We have developed our product strategy by leveraging manufacturing insight gained from our combined experience of >45 years within the Cell & Gene Therapy Industry. Each phase has been designed & prioritised based on the current and our perceived future needs of the Cell & Gene Therapy developer and the growth of the industry…. The excitement is building as we join partners to progress along this drug development pathway.

Kwok Pang, COO of Autolomous

Pragmatic solutions for autologous medicines

©2020 by Autolomous Ltd. Registered office; 20-22 Wenlock Road, London, England, N1 7GU. Company No 11810723, VAT No GB315571512. Linkedin